Using NOX4 siRNA and NOX4 inhibitors, Yamaura et al. showed that NOX4-generated ROS/H2O2 is required for tumor progression in the melanoma transformation phenotype by promoting cell cycle progression through phase G2 [66]. Here, NOX4 is linked to neoplasm.